4.7 Article

MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice

期刊

BLOOD
卷 124, 期 26, 页码 3939-3946

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-09-601567

关键词

-

资金

  1. Cancer Council of Victoria
  2. Sydney Parker Smith postdoctoral research fellowship
  3. Sydney Parker Smith postgraduate research scholarship
  4. Lady Tata Memorial Trust
  5. National Health and Medical Research Council [1016701, 1020363]
  6. Leukemia and Lymphoma Society [7001-03]
  7. University of Melbourne International Research Scholarship
  8. University of Melbourne International Fee Remission scholarship
  9. Australian Postgraduate award
  10. Cancer Therapeutics CRC Top-up scholarship
  11. Australian Government Independent Research Institutes Infrastructure Support Scheme
  12. Victorian State Government Operational Infrastructure Support

向作者/读者索取更多资源

Apoptosis plays a role in normal lymphopoiesis and lymphoid malignancies. Pro-survival MCL-1 is essential for survival of T-cell progenitors, BCL-XL for immature thymocytes, and BCL-2 for mature T cells. Conversely, little is known about the regulators that are required for the survival of T-cell lymphomas. We used constitutive and conditionally gene-targeted mice to investigate which pro-survival BCL-2 family member is required for the sustained survival of thymic lymphomas initiated by loss of p53. Constitutive loss of a single Mcl-1 allele delayed tumor onset. In contrast, lymphomas emerging in p53(-/-) mice in which Mcl-1 could be conditionally deleted had been selected for retention of MCL-1 expression. In contrast, complete loss of BCL-XL had no impact on lymphoma development in p53(-/-) mice. These results demonstrate that thymic lymphomas elicited by loss of p53 must arise from cancer-initiating cells that require MCL-1 for their survival. Acute deletion of both Mcl-1 alleles abrogated the expansion of p53(-/-) lymphomas in mice, whereas inducible loss of BCL-XL had little impact. This reveals that MCL-1 is essential for the sustained survival of these malignant cells and suggests that targeting MCL-1 may be an attractive strategy for the treatment of T-cell lymphoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据